Delve Health Provides the Technology Platform to Design Clinical Trials to Fit a Patient’s Lifestyle

—Not the Other Way Around
A significant number of companies announced delays and cancellations to planned and on-going clinical trials because of COVID-19 lockdowns and social distancing measures. There was a peak of 1,265 trials paused or indefinitely delayed in June 2020—impacting nearly 1,000 companies. Disruptions included delayed initiation or complete withdrawal of planned trials, as well as suspended enrollment or cancellation of on-going trials. The number of disrupted trials has been falling slowly since June 2020, with most current disruptions due to other factors, such as slow enrollment.

Closing The Gap and Raising Patient Care Standards

We all know that clinical trials are a critical part of medical research and that they play a crucial role in the development of new treatments and therapies. However, recruiting patients to participate in clinical studies can be a challenging task. It has been reported that only 9% of the population in the United States, has been invited to participate in clinical research and less than half of those invited actually enroll (Source: HINTS briefs Number 48 (Health Information National Trends Survey). However, the task is not insurmountable; we will identify opportunities to reach potential participants; screen them for eligibility

How to Combine Implementing New Technologies with Patient Perspectives to Decrease Trial Costs and Increase Enrollment

Clinical trials are a crucial part of healthcare—both in the drug development process, as well as giving patients hope. They involve testing the safety and efficacy of potential new therapies and treatments; and they are essential for bringing new medicines to patients. However, clinical studies can be expensive, time-consuming and challenging to successfully conduct. They require significant resources and can often take years to complete. Often, the biggest challenges facing clinical trial sponsors are patient recruitment, compliance and retention. Low enrollment rates can result in delayed or canceled trials, which increases the overall operational costs, as well as delays in

Are eClinical Trials the “New Standard” for Conducting Clinical Research? 

eClinical trials are set to become the new standard for conducting clinical research for many reasons, including their positive effect on reducing the patient burden while increasing patient recruitment and retention; as well as boosting study staff’s efficiency via automated workflows—saving time and cutting operational costs. However, there are growing concerns regarding data privacy when conducting virtual clinical studies, as well as the potential challenges that are created for sponsors to maintain HIPPA and/or GDPR compliance. The best way for sponsors to leverage their use of technology in virtual trials, while ensuring compliance with regulatory bodies and their guidelines, is

Digital Technology Solutions Improve Efficiency—But Also, the Environment 

“Digital Healthcare” and “eClinical Trials” and “Virtual Wards” are all phrases we have heard more and more in recent months. More and more clinical research organizations and healthcare providers and sites have been adopting remote patient monitoring. This recent advancement in conducting how we work with and treat patients has led to a shift in how clinical trials are being designed (i.e., virtual, hybrid, decentralized, traditional), as well as how healthcare is interacting with and treating patients in general—and it is really exciting! Using technology solutions, like Delve Health’s Clinical StudyPal platform, not only pushes us further into the future

Technology Advances How We Design Clinical Trials: Wearables, Devices, and Data

Our article, written by our Co-Founder and CEO, Wessam Sonbol, CSM, CSPO, ICP-ACC, in the Association of Clinical Research Professionals’ (ACRP) Clinical Researcher. Originally published here: Clinical Researcher in December 2022’s issue (Volume 36, Issue 6) In the June 2022 Clinical Researcher, we discussed how the clinical research enterprise embraced newer technology solutions more quickly than usual due to the challenges the COVID-19 pandemic forced us to overcome in order to keep clinical trials moving forward. In just the short time since that article, clinical researchers and study teams around the globe have widely adopted technology solutions that will forever

Scroll to Top